The company provided the updated long-term target ahead of its investor day. “We are proud of the strong and resilient foundation we have built that enables us to deliver compelling future growth,” said Jason Hollar, Chief Executive Officer of Cardinal Health (CAH). “We look forward to highlighting the significant opportunities in front of Cardinal Health as we continue to evolve to reach our full potential.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health CEO: Our industry has been resilient, stronger than usual
- Cardinal Health to hold an investor day
- Cardinal Health’s Strong Execution and Industry Tailwinds Support Buy Rating with Potential for Double-Digit EPS Growth
- Cardinal Health price target raised to $170 from $165 at BofA
- Citius Oncology enters distribution services agreement with Cardinal Health